Assembly Biosciences, Inc. ( ASMB) - Stock Earnings
ASMB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
ASMB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 22.1 million USD | 42.5 million USD |
| 2026Q1 | -9.1 million USD | 8.2 million USD |
| 2026Q2 | -3.9 million USD | 13.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ASMB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -61.2 million USD | 7.2 million USD |
| 2024 | -40.2 million USD | 28.5 million USD |
| 2025 | -6.1 million USD | 72.3 million USD |
| 2026 Est. | — | — |
ASMB
Price: $20.09
Earnings Per Share: 1.24 USD
P/E Ratio: 24.20
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 311844
Ebitda: -12.4 millionMarket Capitalization: 446.7 million